First round to Amgen in EPO battle
Article Abstract:
US District Judge William Young rules in favor of Amgen in a erythropoietin patent infringement suit filed against Transkaryotic Therapies.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Gene pill patents a surprise for gene therapy
Article Abstract:
A gene pill composed of DNA encoding insulin has been patented by University of California researchers. The gene pill claims a novel method for lowering blood glucose.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
US FDA approves new class of HIV therapeutics
Article Abstract:
Hoffmann-La Roche's Fuzeon is the first synthetic peptide drug from a commercial enterprise. The US Food and Drug Administration approved the AIDS drug for 15,000 patients in 2003.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: High margin products promise to relieve the pain of opiates. Pfizer
- Abstracts: All it takes is money: As accountancy firms diversify and become more global, they are going to have to find new and inventive ways of funding their expansion
- Abstracts: US trends may lead to inflation surprise. Divorced from the dollar. The real threat to Wall Street
- Abstracts: Tech companies with minimal risk. Take a slice of their profits. Shares that must climb
- Abstracts: The sun rises in the east. Dining out. One for all?